The potential of positron-emission tomography to study anticancer-drug resistance
Nat Rev Cancer
.
2004 Jun;4(6):457-69.
doi: 10.1038/nrc1368.
Authors
Catharine M L West
1
,
Terry Jones
,
Pat Price
Affiliation
1
Academic Department of Radiation Oncology and Manchester Molecular Imaging Centre, University of Manchester, Christie NHS Trust Hospital, Wilmslow Road, Manchester, M20 4BX, United Kingdom. catharine.west@man.ac.uk
PMID:
15170448
DOI:
10.1038/nrc1368
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents / pharmacokinetics*
Antineoplastic Agents / pharmacology*
Drug Resistance, Neoplasm*
Humans
Neoplasms / diagnostic imaging*
Neoplasms / physiopathology*
Tomography, Emission-Computed*
Substances
Antineoplastic Agents